South Korea Cancer Diagnostics Market Report by Product (Consumables, Instruments), Technology (IVD Testing, Imaging, Biopsy Technique), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Region 2026-2034

July 2026 | 115 pages | ID: S563C76533EBEN
IMARC Group

Abstracts

South Korea cancer diagnostics market size reached USD 4.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.32% during 2026-2034. The introduction of a diverse range of advanced techniques and technologies, including magnetic resonance imaging (MRI), X-rays, and sophisticated laboratory tests, that analyze blood, tissue, and genetic samples is primarily driving the regional market.

Cancer diagnostics involves identifying and ascertaining the existence, category, and stage of cancer in individuals. This field incorporates various methods and technologies, including magnetic resonance imaging (MRI), X-rays, and laboratory tests that analyze blood, tissue, and genetic samples. The primary goal is to enable healthcare professionals to precisely identify and evaluate cancerous developments within the body. Additionally, it empowers healthcare providers to enhance patient outcomes by customizing interventions based on the unique characteristics of the disease. This process aids in refining treatment decisions and formulating personalized therapeutic approaches.

SOUTH KOREA CANCER DIAGNOSTICS MARKET TRENDS:

The South Korea cancer diagnostics market represents a critical aspect of the nation's healthcare landscape, playing a pivotal role in early detection, precise identification, and effective management of various forms of cancer. One of the primary objectives of the cancer diagnostics market in South Korea is to equip healthcare professionals with the tools necessary for accurate and timely detection of cancer. Additionally, these diagnostic tools enable healthcare providers to ascertain the presence, type, and stage of cancer in individuals, laying the foundation for informed decision-making regarding treatment strategies. Furthermore, the South Korea cancer diagnostics market contributes significantly to the optimization of patient outcomes by facilitating personalized interventions. Through the analysis of blood, tissue, and genetic samples, healthcare professionals can tailor treatment approaches to the specific characteristics of the disease, leading to more effective and targeted therapeutic strategies. As a result, the cancer diagnostics market in South Korea not only aids in the early detection of cancer but also empowers healthcare providers to make informed decisions regarding treatment plans. This approach not only improves patient outcomes but also contributes to the overall effectiveness of cancer management in the country. With a focus on cutting-edge technologies and personalized approaches, the South Korea cancer diagnostics market will remain a crucial component in the nation's efforts to combat and manage the complexities of the disease over the forecasted period.

SOUTH KOREA CANCER DIAGNOSTICS MARKET SEGMENTATION:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on product, technology, application, and end user.

Product Insights:

• Consumables
• Antibodies
• Kits and Reagents
• Probes
• Others
• Instruments
• Pathology-Based Instruments
• Imaging Instruments
• Biopsy Instruments

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables (antibodies, kits and reagents, probes, and others) and instruments (pathology-based instruments, imaging instruments, and biopsy instruments).

Technology Insights:

• IVD Testing
• Polymerase Chain Reaction (PCR)
• In Situ Hybridization (ISH)
• Immunohistochemistry (IHC)
• Next-Generation Sequencing (NGS)
• Microarrays
• Flow Cytometry
• Immunoassays
• Others
• Imaging
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Positron Emission Tomography (PET)
• Mammography
• Ultrasound
• Biopsy Technique

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes IVD testing (polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next-generation sequencing (NGS), microarrays, flow cytometry, immunoassays, and others), imaging (magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, and ultrasound), and biopsy technique.

Application Insights:

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma

The report has provided a detailed breakup and analysis of the market based on the application. This includes breast cancer, lung cancer, colorectal cancer, melanoma, and others.

End User Insights:

• Hospitals and Clinics
• Diagnostic Laboratories

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, diagnostic laboratories, and others.

Regional Insights:

• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)

The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and Others.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea cancer diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea cancer diagnostics market?
What is the breakup of the South Korea cancer diagnostics market on the basis of product?
What is the breakup of the South Korea cancer diagnostics market on the basis of technology?
What is the breakup of the South Korea cancer diagnostics market on the basis of application?
What is the breakup of the South Korea cancer diagnostics market on the basis of end user?
What are the various stages in the value chain of the South Korea cancer diagnostics market?
What are the key driving factors and challenges in the South Korea cancer diagnostics?
What is the structure of the South Korea cancer diagnostics market and who are the key players?
What is the degree of competition in the South Korea cancer diagnostics market?

Contents

1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 SOUTH KOREA CANCER DIAGNOSTICS MARKET - INTRODUCTION

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 SOUTH KOREA CANCER DIAGNOSTICS MARKET LANDSCAPE

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 SOUTH KOREA CANCER DIAGNOSTICS MARKET - BREAKUP BY PRODUCT

6.1 Consumables
  6.1.1 Overview
  6.1.2 Historical and Current Market Trends (2020-2025)
  6.1.3 Market Segmentation
    6.1.3.1 Antibodies
    6.1.3.2 Kits and Reagents
    6.1.3.3 Probes
    6.1.3.4 Others
  6.1.4 Market Forecast (2026-2034)
6.2 Instruments
  6.2.1 Overview
  6.2.2 Historical and Current Market Trends (2020-2025)
  6.2.3 Market Segmentation
    6.2.3.1 Pathology-Based Instruments
    6.2.3.2 Imaging Instruments
    6.2.3.3 Biopsy Instruments
  6.2.4 Market Forecast (2026-2034)

7 SOUTH KOREA CANCER DIAGNOSTICS MARKET - BREAKUP BY TECHNOLOGY

7.1 IVD Testing
  7.1.1 Overview
  7.1.2 Historical and Current Market Trends (2020-2025)
  7.1.3 Market Segmentation
    7.1.3.1 Polymerase Chain Reaction (PCR)
    7.1.3.2 In Situ Hybridization (ISH)
    7.1.3.3 Immunohistochemistry (IHC)
    7.1.3.4 Next-Generation Sequencing (NGS)
    7.1.3.5 Microarrays
    7.1.3.6 Flow Cytometry
    7.1.3.7 Immunoassays
    7.1.3.8 Others
  7.1.4 Market Forecast (2026-2034)
7.2 Imaging
  7.2.1 Overview
  7.2.2 Historical and Current Market Trends (2020-2025)
  7.2.3 Market Segmentation
    7.2.3.1 Magnetic Resonance Imaging (MRI)
    7.2.3.2 Computed Tomography (CT)
    7.2.3.3 Positron Emission Tomography (PET)
    7.2.3.4 Mammography
    7.2.3.5 Ultrasound
  7.2.4 Market Forecast (2026-2034)
7.3 Biopsy Technique
  7.3.1 Overview
  7.3.2 Historical and Current Market Trends (2020-2025)
  7.3.3 Market Forecast (2026-2034)

8 SOUTH KOREA CANCER DIAGNOSTICS MARKET - BREAKUP BY APPLICATION

8.1 Breast Cancer
  8.1.1 Overview
  8.1.2 Historical and Current Market Trends (2020-2025)
  8.1.3 Market Forecast (2026-2034)
8.2 Lung Cancer
  8.2.1 Overview
  8.2.2 Historical and Current Market Trends (2020-2025)
  8.2.3 Market Forecast (2026-2034)
8.3 Colorectal Cancer
  8.3.1 Overview
  8.3.2 Historical and Current Market Trends (2020-2025)
  8.3.3 Market Forecast (2026-2034)
8.4 Melanoma
  8.4.1 Overview
  8.4.2 Historical and Current Market Trends (2020-2025)
  8.4.3 Market Forecast (2026-2034)
8.5 Others
  8.5.1 Historical and Current Market Trends (2020-2025)
  8.5.2 Market Forecast (2026-2034)

9 SOUTH KOREA CANCER DIAGNOSTICS MARKET - BREAKUP BY END USER

9.1 Hospitals and Clinics
  9.1.1 Overview
  9.1.2 Historical and Current Market Trends (2020-2025)
  9.1.3 Market Forecast (2026-2034)
9.2 Diagnostic Laboratories
  9.2.1 Overview
  9.2.2 Historical and Current Market Trends (2020-2025)
  9.2.3 Market Forecast (2026-2034)
9.3 Others
  9.3.1 Historical and Current Market Trends (2020-2025)
  9.3.2 Market Forecast (2026-2034)

10 SOUTH KOREA CANCER DIAGNOSTICS MARKET – BREAKUP BY REGION

10.1 Seoul Capital Area
  10.1.1 Overview
  10.1.2 Historical and Current Market Trends (2020-2025)
  10.1.3 Market Breakup by Product
  10.1.4 Market Breakup by Technology
  10.1.5 Market Breakup by Application
  10.1.6 Market Breakup by End User
  10.1.7 Key Players
  10.1.8 Market Forecast (2026-2034)
10.2 Yeongnam (Southeastern Region)
  10.2.1 Overview
  10.2.2 Historical and Current Market Trends (2020-2025)
  10.2.3 Market Breakup by Product
  10.2.4 Market Breakup by Technology
  10.2.5 Market Breakup by Application
  10.2.6 Market Breakup by End User
  10.2.7 Key Players
  10.2.8 Market Forecast (2026-2034)
10.3 Honam (Southwestern Region)
  10.3.1 Overview
  10.3.2 Historical and Current Market Trends (2020-2025)
  10.3.3 Market Breakup by Product
  10.3.4 Market Breakup by Technology
  10.3.5 Market Breakup by Application
  10.3.6 Market Breakup by End User
  10.3.7 Key Players
  10.3.8 Market Forecast (2026-2034)
10.4 Hoseo (Central Region)
  10.4.1 Overview
  10.4.2 Historical and Current Market Trends (2020-2025)
  10.4.3 Market Breakup by Product
  10.4.4 Market Breakup by Technology
  10.4.5 Market Breakup by Application
  10.4.6 Market Breakup by End User
  10.4.7 Key Players
  10.4.8 Market Forecast (2026-2034)
10.5 Others
  10.5.1 Historical and Current Market Trends (2020-2025)
  10.5.2 Market Forecast (2026-2034)

11 SOUTH KOREA CANCER DIAGNOSTICS MARKET – COMPETITIVE LANDSCAPE

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 PROFILES OF KEY PLAYERS

12.1 Company A
  12.1.1 Business Overview
  12.1.2 Product Portfolio
  12.1.3 Business Strategies
  12.1.4 SWOT Analysis
  12.1.5 Major News and Events
12.2 Company B
  12.2.1 Business Overview
  12.2.2 Product Portfolio
  12.2.3 Business Strategies
  12.2.4 SWOT Analysis
  12.2.5 Major News and Events
12.3 Company C
  12.3.1 Business Overview
  12.3.2 Product Portfolio
  12.3.3 Business Strategies
  12.3.4 SWOT Analysis
  12.3.5 Major News and Events
12.4 Company D
  12.4.1 Business Overview
  12.4.2 Product Portfolio
  12.4.3 Business Strategies
  12.4.4 SWOT Analysis
  12.4.5 Major News and Events
12.5 Company E
  12.5.1 Business Overview
  12.5.2 Product Portfolio
  12.5.3 Business Strategies
  12.5.4 SWOT Analysis
  12.5.5 Major News and Events

13 SOUTH KOREA CANCER DIAGNOSTICS MARKET - INDUSTRY ANALYSIS

13.1 Drivers, Restraints, and Opportunities
  13.1.1 Overview
  13.1.2 Drivers
  13.1.3 Restraints
  13.1.4 Opportunities
13.2 Porters Five Forces Analysis
  13.2.1 Overview
  13.2.2 Bargaining Power of Buyers
  13.2.3 Bargaining Power of Suppliers
  13.2.4 Degree of Competition
  13.2.5 Threat of New Entrants
  13.2.6 Threat of Substitutes
13.3 Value Chain Analysis

14 APPENDIX